|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
|
Aug 28
|
Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk
|
|
Aug 27
|
Siemens Healthineers to grow PET imaging with purchase of Novartis assets
|
|
Aug 26
|
Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are Caveats
|
|
Aug 26
|
European Equities Close Mixed in Monday Trading; EU Trade Balance Records Surplus for 4th Straight Quarter
|
|
Aug 26
|
Siemens Healthineers to acquire Novartis’ diagnostics arm
|
|
Aug 2
|
Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues
|
|
Aug 2
|
Q2 2024 Ionis Pharmaceuticals Inc Earnings Call
|
|
Jul 30
|
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
|
Jul 30
|
FDA grants priority review for Novartis’ leukaemia treatment
|
|
Jul 25
|
Dren Bio and Novartis link on bispecific antibodies for cancer
|
|
Jul 24
|
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
|
|
Jul 24
|
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
|
Jun 26
|
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
|
|
Jun 26
|
Pharma M&A: The top high value deals in 2023
|
|
Jun 25
|
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
|
|
Jun 25
|
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
|
|
Jun 21
|
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
|
|
Jun 20
|
Here's Why Novartis (NVS) is a Strong Momentum Stock
|
|
Jun 11
|
Is Novartis AG (NYSE:NVS) Investors’ Favorite International Dividend Stock?
|